Does the media prefer COR or ELV?

In the previous week, Elevance Health had 19 more articles in the media than Cencora. MarketBeat recorded 25 mentions for Elevance Health and 6 mentions for Cencora. Elevance Health's average media sentiment score of 1.65 beat Cencora's score of 0.75 indicating that Elevance Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Elevance Health 24 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has better earnings & valuation, COR or MCK?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.16 $1.55B $13.04 20.86 McKesson $403.43B 0.22 $4.76B $38.47 19.50

Is COR or MCK more profitable?

McKesson has a net margin of 1.18% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat McKesson's return on equity. Company Net Margins Return on Equity Return on Assets Cencora 0.78% 135.20% 4.20% McKesson 1.18% -345.35% 5.85%

Does the media favor COR or MCK?

In the previous week, McKesson had 36 more articles in the media than Cencora. MarketBeat recorded 42 mentions for McKesson and 6 mentions for Cencora. McKesson's average media sentiment score of 1.43 beat Cencora's score of 0.75 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive McKesson 37 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer COR or CAH?

In the previous week, Cardinal Health had 3 more articles in the media than Cencora. MarketBeat recorded 9 mentions for Cardinal Health and 6 mentions for Cencora. Cardinal Health's average media sentiment score of 0.86 beat Cencora's score of 0.75 indicating that Cardinal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cardinal Health 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, COR or HSIC?

Cencora has higher revenue and earnings than Henry Schein. Cencora is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.16 $1.55B $13.04 20.86 Henry Schein $13.18B 0.69 $398M $3.31 24.15

Is COR or HSIC more profitable?

Henry Schein has a net margin of 2.95% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Henry Schein's return on equity. Company Net Margins Return on Equity Return on Assets Cencora 0.78% 135.20% 4.20% Henry Schein 2.95% 15.44% 5.53%

Does the media refer more to COR or HSIC?

In the previous week, Cencora had 2 more articles in the media than Henry Schein. MarketBeat recorded 6 mentions for Cencora and 4 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.10 beat Cencora's score of 0.75 indicating that Henry Schein is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Henry Schein 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation & earnings, COR or CVS?

CVS Health has higher revenue and earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cencora $321.33B 0.16 $1.55B $13.04 20.86 CVS Health $402.07B 0.31 $1.77B $2.27 43.29

Is COR or CVS more profitable?

Cencora has a net margin of 0.78% compared to CVS Health's net margin of 0.72%. Cencora's return on equity of 135.20% beat CVS Health's return on equity. Company Net Margins Return on Equity Return on Assets Cencora 0.78% 135.20% 4.20% CVS Health 0.72% 11.88% 3.54%

Does the media refer more to COR or CVS?

In the previous week, CVS Health had 39 more articles in the media than Cencora. MarketBeat recorded 45 mentions for CVS Health and 6 mentions for Cencora. CVS Health's average media sentiment score of 1.35 beat Cencora's score of 0.75 indicating that CVS Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cencora 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVS Health 38 Very Positive mention(s) 5 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Cencora (COR) Competitors

$271.99 +0.16 (+0.06%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$275.42 +3.43 (+1.26%)

As of 06/18/2026 06:33 PM Eastern

Compare

COR vs. ELV, MCK, CAH, HSIC, and CVS

Should you buy Cencora stock or one of its competitors? MarketBeat compares Cencora with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cencora include Elevance Health (ELV), McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), and CVS Health (CVS). These companies are all part of the "medical" sector.

How does Cencora compare to Elevance Health?

Cencora (NYSE:COR) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, media sentiment, analyst recommendations and dividends.

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.9%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.8%. Cencora pays out 18.4% of its earnings in the form of a dividend. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and Elevance Health has increased its dividend for 14 consecutive years.

Elevance Health has a net margin of 2.62% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Elevance Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
Elevance Health	2.62%	15.58%	5.57%

Cencora has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

In the previous week, Elevance Health had 19 more articles in the media than Cencora. MarketBeat recorded 25 mentions for Elevance Health and 6 mentions for Cencora. Elevance Health's average media sentiment score of 1.65 beat Cencora's score of 0.75 indicating that Elevance Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Elevance Health	24 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Cencora currently has a consensus price target of $374.00, suggesting a potential upside of 37.51%. Elevance Health has a consensus price target of $416.11, suggesting a potential upside of 7.03%. Given Cencora's stronger consensus rating and higher probable upside, analysts clearly believe Cencora is more favorable than Elevance Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.80
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61

Elevance Health has lower revenue, but higher earnings than Cencora. Elevance Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.16	$1.55B	$13.04	20.86
Elevance Health	$199.13B	0.42	$5.66B	$23.51	16.54

97.5% of Cencora shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.4% of Cencora shares are held by company insiders. Comparatively, 0.3% of Elevance Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Elevance Health beats Cencora on 10 of the 19 factors compared between the two stocks.

How does Cencora compare to McKesson?

Cencora (NYSE:COR) and McKesson (NYSE:MCK) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

Cencora currently has a consensus price target of $374.00, suggesting a potential upside of 37.51%. McKesson has a consensus price target of $960.53, suggesting a potential upside of 28.03%. Given Cencora's higher probable upside, equities research analysts clearly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.80
McKesson	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

McKesson has a net margin of 1.18% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
McKesson	1.18%	-345.35%	5.85%

Cencora has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, McKesson has a beta of 0.31, meaning that its share price is 69% less volatile than the broader market.

In the previous week, McKesson had 36 more articles in the media than Cencora. MarketBeat recorded 42 mentions for McKesson and 6 mentions for Cencora. McKesson's average media sentiment score of 1.43 beat Cencora's score of 0.75 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
McKesson	37 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.9%. McKesson pays an annual dividend of $3.28 per share and has a dividend yield of 0.4%. Cencora pays out 18.4% of its earnings in the form of a dividend. McKesson pays out 8.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has raised its dividend for 15 consecutive years and McKesson has raised its dividend for 17 consecutive years.

97.5% of Cencora shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 0.4% of Cencora shares are held by company insiders. Comparatively, 0.1% of McKesson shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.16	$1.55B	$13.04	20.86
McKesson	$403.43B	0.22	$4.76B	$38.47	19.50

Summary

McKesson beats Cencora on 12 of the 19 factors compared between the two stocks.

How does Cencora compare to Cardinal Health?

Cencora (NYSE:COR) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, analyst recommendations, earnings, media sentiment and risk.

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.9%. Cardinal Health pays an annual dividend of $2.04 per share and has a dividend yield of 0.9%. Cencora pays out 18.4% of its earnings in the form of a dividend. Cardinal Health pays out 31.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cencora has increased its dividend for 15 consecutive years and Cardinal Health has increased its dividend for 29 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cencora has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.52, meaning that its share price is 48% less volatile than the broader market.

Cencora presently has a consensus target price of $374.00, suggesting a potential upside of 37.51%. Cardinal Health has a consensus target price of $246.93, suggesting a potential upside of 11.19%. Given Cencora's higher probable upside, equities research analysts clearly believe Cencora is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.80
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

Cardinal Health has lower revenue, but higher earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.16	$1.55B	$13.04	20.86
Cardinal Health	$222.58B	0.23	$1.56B	$6.54	33.96

97.5% of Cencora shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 0.4% of Cencora shares are held by insiders. Comparatively, 0.1% of Cardinal Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cencora has a net margin of 0.78% compared to Cardinal Health's net margin of 0.62%. Cencora's return on equity of 135.20% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
Cardinal Health	0.62%	-92.61%	4.46%

In the previous week, Cardinal Health had 3 more articles in the media than Cencora. MarketBeat recorded 9 mentions for Cardinal Health and 6 mentions for Cencora. Cardinal Health's average media sentiment score of 0.86 beat Cencora's score of 0.75 indicating that Cardinal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cardinal Health	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cardinal Health beats Cencora on 10 of the 19 factors compared between the two stocks.

How does Cencora compare to Henry Schein?

Cencora (NYSE:COR) and Henry Schein (NASDAQ:HSIC) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

Cencora has higher revenue and earnings than Henry Schein. Cencora is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.16	$1.55B	$13.04	20.86
Henry Schein	$13.18B	0.69	$398M	$3.31	24.15

Cencora has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, Henry Schein has a beta of 0.82, meaning that its share price is 18% less volatile than the broader market.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 96.6% of Henry Schein shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Comparatively, 0.9% of Henry Schein shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Henry Schein has a net margin of 2.95% compared to Cencora's net margin of 0.78%. Cencora's return on equity of 135.20% beat Henry Schein's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
Henry Schein	2.95%	15.44%	5.53%

Cencora currently has a consensus price target of $374.00, suggesting a potential upside of 37.51%. Henry Schein has a consensus price target of $87.85, suggesting a potential upside of 9.92%. Given Cencora's stronger consensus rating and higher possible upside, research analysts plainly believe Cencora is more favorable than Henry Schein.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.80
Henry Schein	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

In the previous week, Cencora had 2 more articles in the media than Henry Schein. MarketBeat recorded 6 mentions for Cencora and 4 mentions for Henry Schein. Henry Schein's average media sentiment score of 1.10 beat Cencora's score of 0.75 indicating that Henry Schein is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Henry Schein	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Cencora beats Henry Schein on 9 of the 16 factors compared between the two stocks.

How does Cencora compare to CVS Health?

Cencora (NYSE:COR) and CVS Health (NYSE:CVS) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and media sentiment.

97.5% of Cencora shares are owned by institutional investors. Comparatively, 80.7% of CVS Health shares are owned by institutional investors. 0.4% of Cencora shares are owned by insiders. Comparatively, 0.9% of CVS Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cencora presently has a consensus target price of $374.00, suggesting a potential upside of 37.51%. CVS Health has a consensus target price of $100.68, suggesting a potential upside of 2.46%. Given Cencora's higher possible upside, research analysts clearly believe Cencora is more favorable than CVS Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cencora	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.80
CVS Health	0 Sell rating(s)	4 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.85

CVS Health has higher revenue and earnings than Cencora. Cencora is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cencora	$321.33B	0.16	$1.55B	$13.04	20.86
CVS Health	$402.07B	0.31	$1.77B	$2.27	43.29

Cencora has a net margin of 0.78% compared to CVS Health's net margin of 0.72%. Cencora's return on equity of 135.20% beat CVS Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cencora	0.78%	135.20%	4.20%
CVS Health	0.72%	11.88%	3.54%

In the previous week, CVS Health had 39 more articles in the media than Cencora. MarketBeat recorded 45 mentions for CVS Health and 6 mentions for Cencora. CVS Health's average media sentiment score of 1.35 beat Cencora's score of 0.75 indicating that CVS Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cencora	4 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVS Health	38 Very Positive mention(s)	5 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.9%. CVS Health pays an annual dividend of $2.66 per share and has a dividend yield of 2.7%. Cencora pays out 18.4% of its earnings in the form of a dividend. CVS Health pays out 117.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Cencora has increased its dividend for 15 consecutive years and CVS Health has increased its dividend for 4 consecutive years.

Cencora has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, CVS Health has a beta of 0.62, meaning that its share price is 38% less volatile than the broader market.

Summary

CVS Health beats Cencora on 11 of the 19 factors compared between the two stocks.

Get Cencora News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COR vs. The Competition

Export

Metric	Cencora	Medical Services Industry	Medical Sector	NYSE Exchange
Market Cap	$52.89B	$8.76B	$6.43B	$23.21B
Dividend Yield	0.88%	1.73%	2.68%	4.06%
P/E Ratio	20.86	24.73	24.75	31.61
Price / Sales	0.16	16.61	530.01	112.15
Price / Cash	12.58	102.97	45.07	24.44
Price / Book	30.19	5.64	10.80	4.68
Net Income	$1.55B	$179.69M	$3.57B	$1.08B
7 Day Performance	-3.40%	1.96%	0.73%	-0.82%
1 Month Performance	2.72%	4.19%	1.35%	1.61%
1 Year Performance	-7.38%	6.36%	29.31%	24.87%

Cencora Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COR Cencora	4.8348 of 5 stars	$271.99 +0.1%	$374.00 +37.5%	-8.4%	$52.89B	$321.33B	20.86	51,000	News Coverage High Trading Volume
ELV Elevance Health	4.53 of 5 stars	$401.82 -0.6%	$416.11 +3.6%	+3.5%	$87.23B	$199.13B	17.08	97,100	Positive News
MCK McKesson	4.9335 of 5 stars	$778.18 -0.7%	$960.53 +23.4%	+2.9%	$93.42B	$403.43B	20.20	43,000	Trending News Insider Trade
CAH Cardinal Health	4.3721 of 5 stars	$226.04 +1.0%	$246.93 +9.2%	+34.2%	$52.87B	$250.74B	34.52	57,700	News Coverage
HSIC Henry Schein	3.7618 of 5 stars	$81.20 -0.1%	$87.85 +8.2%	+12.4%	$9.25B	$13.18B	24.52	25,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:COR) was last updated on 6/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cencora (COR) Competitors

COR vs. ELV, MCK, CAH, HSIC, and CVS

How does Cencora compare to Elevance Health?

Summary

How does Cencora compare to McKesson?

Summary

How does Cencora compare to Cardinal Health?

Summary

How does Cencora compare to Henry Schein?

Summary

How does Cencora compare to CVS Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COR vs. The Competition

Cencora Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cencora (COR) Competitors

COR vs. ELV, MCK, CAH, HSIC, and CVS

How does Cencora compare to Elevance Health?

Is COR or ELV a better dividend stock?

Is COR or ELV more profitable?

Which has more risk and volatility, COR or ELV?

Does the media prefer COR or ELV?

Do analysts recommend COR or ELV?

Which has preferable earnings and valuation, COR or ELV?

Do insiders and institutionals hold more shares of COR or ELV?

Summary

How does Cencora compare to McKesson?

Do analysts recommend COR or MCK?

Is COR or MCK more profitable?

Which has more risk & volatility, COR or MCK?

Does the media favor COR or MCK?

Is COR or MCK a better dividend stock?

Do insiders & institutionals believe in COR or MCK?

Which has better earnings & valuation, COR or MCK?

Summary

How does Cencora compare to Cardinal Health?

Is COR or CAH a better dividend stock?

Which has more volatility and risk, COR or CAH?

Do analysts rate COR or CAH?

Which has preferable valuation and earnings, COR or CAH?

Do insiders and institutionals have more ownership in COR or CAH?

Is COR or CAH more profitable?

Does the media prefer COR or CAH?

Summary

How does Cencora compare to Henry Schein?

Which has higher earnings & valuation, COR or HSIC?

Which has more volatility & risk, COR or HSIC?

Do insiders and institutionals hold more shares of COR or HSIC?

Is COR or HSIC more profitable?

Do analysts rate COR or HSIC?

Does the media refer more to COR or HSIC?

Summary

How does Cencora compare to CVS Health?

Do insiders & institutionals have more ownership in COR or CVS?

Do analysts rate COR or CVS?

Which has better valuation & earnings, COR or CVS?

Is COR or CVS more profitable?

Does the media refer more to COR or CVS?

Is COR or CVS a better dividend stock?

Which has more risk & volatility, COR or CVS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COR vs. The Competition

Cencora Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools